GT Biopharma
GTBP
GTBP
53 hedge funds and large institutions have $16.7M invested in GT Biopharma in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 23 increasing their positions, 6 reducing their positions, and 11 closing their positions.
Holders
53
Holders Change
–
Holders Change %
0%
% of All Funds
0.82%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
23
Reduced
6
Closed
11
Calls
$334K
Puts
$239K
Net Calls
+$95K
Net Calls Change
+$467K
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$3.68M |
| 2 |
2
Renaissance Technologies
New York
|
$935K |
| 3 |
3
Morgan Stanley
New York
|
$1.35M |
| 4 |
4
Two Sigma Advisers
New York
|
$366K |
| 5 |
5
State Street
Boston,
Massachusetts
|
$1.6M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
BBPWM
51
Blue Bell Private Wealth Management
Blue Bell,
Pennsylvania
| $1K | +$1K | +10 | New |
|
|
APA
52
American Portfolios Advisors
Holbrook,
New York
| $43 | -$94 | – | – |
|
|
SCP
53
Silverleafe Capital Partners
Germantown,
Tennessee
| – | -$708K | -3,500 | Closed |
|
54
Millennium Management
New York
| – | -$230K | -1,138 | Closed |
|
|
CSS
55
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$227K | -1,123 | Closed |
|
|
ECM
56
ExodusPoint Capital Management
New York
| – | -$150K | -740 | Closed |
|
57
Marshall Wace
London,
United Kingdom
| – | -$112K | -553 | Closed |
|
58
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$96K | -477 | Closed |
|
59
Invesco
Atlanta,
Georgia
| – | -$88K | -433 | Closed |
|
60
Russell Investments Group
London,
United Kingdom
| – | -$64K | -321 | Closed |
|
|
HFM
61
Hartford Financial Management
Hartford,
Connecticut
| – | -$3K | -17 | Closed |
|
62
Fidelity Investments
Boston,
Massachusetts
| – | -$1K | -4 | Closed |
|
|
HI
63
Harbour Investments
Madison,
Wisconsin
| – | -$1K | -3 | Closed |
|